AlphaFold 3.1 delivers a major accuracy boost in predicting protein-small molecule interactions and protein-protein interfaces, reducing RMSD errors by up to 40% on difficult targets. The update enables faster drug discovery cycles and better virtual screening for novel therapeutics.